Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab.
SKIN The Journal of Cutaneous Medicine,
[S. l.], v. 4, n. 5, p. s41, 2020. DOI:
10.25251/skin.4.supp.41. DisponÃvel em:
https://skin.dermsquared.com/skin/article/view/990. Acesso em: 28 apr. 2025.